Virus in Milk Tied to Breast Cancer Surge

A virus lurking in your daily glass of milk might explain up to half of breast cancer cases, silently jumping from cows to women.

Story Highlights

BLV infects 30-50% of U.S. dairy cows and shows up in 80% of breast cancer tissues versus 41% in healthy controls.
2020 meta-analysis across 9 studies calculates 2.57 odds ratio linking BLV to breast cancer risk.
Recent 2024 research pins 51.82% attributable risk, with BLV often predating tumors in 74% of cases.
High-dairy regions like U.S. West Coast and South Brazil report strongest human prevalence rates.
No human vaccines exist, but dairy avoidance could prevent 37-52% of cases if causal link holds.

Discovery of BLV in Human Breast Tissue

Gertrude Buehring at UC Berkeley detected Bovine Leukemia Virus DNA in human breast tissue in 2015. Cancer samples tested positive at 80%, compared to 41% in controls. BLV, a deltaretrovirus, infects nearly 50% of U.S. dairy cows, causing leukemia in cattle. Researchers found the virus predated cancer development in 74% of cases, hinting at causation. This marked the first strong evidence of zoonotic transmission fueling human tumors.

Brazilian studies from 2019-2020 echoed these findings. Tumor tissues showed 30.5-95.9% BLV positivity against 13.9-59% in healthy samples. Transmission likely occurs through unpasteurized milk, undercooked meat, or infected blood cells. Pasteurization fails to eliminate cell-bound viruses completely. These results challenge assumptions about food safety in dairy-heavy diets.

Scientific Evidence Builds a Case

A 2020 meta-analysis pooled data from 9 studies, yielding an odds ratio of 2.57 for breast cancer in BLV-positive individuals. Prevalence varies by detection method—PCR or immunohistochemistry—and region. U.S. West Coast buffy coat cells carry BLV in 38% of people. Viruses already cause 20% of human cancers through oncogene activation or chronic inflammation, like HPV in cervical cancer.

Precedents exist with mouse mammary tumor virus, a similar retrovirus tied to human breast cancer. BLV mirrors this pattern, inserting into mammary cells. A 2024 study quantified 51.82% attributable risk, the strongest causality signal yet. BLV appears in diverse human cells, including platelets and T-cells, broadening exposure pathways.

Stakeholders and Industry Resistance

Buehring advocates BLV as a modifiable risk factor, urging cattle herd controls. Brazilian researchers like Schwingel and Delaramina link higher rates to dairy consumption. Public health voices, including NutritionFacts.org, amplify warnings without industry pushback studies. Dairy stakeholders, overseeing a $40 billion U.S. sector, face economic threats from screening mandates. FDA and USDA conduct no routine milk tests for BLV.

Could Bovine Leukemia Virus be a Cause of Breast Cancer? https://t.co/cVWnZPoDIH

— Frank Herd (@frankherdj) May 5, 2026

Cancer organizations remain silent despite robust peer-reviewed data from NIH and PMC. Academics battle agribusiness skepticism over detection variances.

Potential Impacts and Next Steps

Short-term, women in high-dairy areas could cut risk via dietary shifts, potentially preventing 37-52% of cases. Long-term, proven causation demands livestock reforms and oncology antivirals. Dairy sales may dip, but herd screening costs pale against breast cancer’s toll. Social momentum builds for plant-based options; policy eyes pasteurization limits and zoonotic regs.